Skip to main content

Table 3 Cox regression analysis for the influence of Stage and cytoplasmic and nuclear CD133 expression on OS and RFS in hepatocellular carcinoma patients

From: The effects of the location of cancer stem cell marker CD133 on the prognosis of hepatocellular carcinoma patients

  

OS

   

RFS

  

Variables

HR

Unfavorable/Favorable

p

(95% CI)

HR

Unfavorable/Favorable

p

(95% CI)

CD133 (Cytoplasm)

2.100

High/ Low

0.028

1.082–4.075

1.946

High/ Low

0.046

1.012–3.745

CD133 (Nucleus)

2.347

Low/ High

0.023

1.122–4.907

2.550

Low/ High

0.012

1.228–5.296

Stage

3.092

II, III/ I

0.012

1.282–7.457

3.460

III, IV/ I, II

0.005

1.441–8.308

  1. RR was adjusted for CD133 (Cytoplasm), CD133 (Nucleus) and tumor stage
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us